| Pharmaceutical active ingredients: |
| Cephalexin |
| Available forms, composition and doses of Kefalospes: |
| N / A |
| Kefalospes medical category: |
| Human:Cephalosporins first-generation |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| J01DB01 - Cefalexin |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Unidentified Pharmaceutical Company |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
K-Bait | Calcium Polystyrene Sulfonate | Unidentified Pharmaceutical Company |
| K-Contin | Potassium Chloride | Unidentified Pharmaceutical Company |
| Kecimeton | Fluorouracil | Unidentified Pharmaceutical Company |
| Kedavon | Thalidomide | Unidentified Pharmaceutical Company |
| Keenate | Sodium Propionate | Unidentified Pharmaceutical Company |
| Kefglycin | Cephaloglycin | Unidentified Pharmaceutical Company |
| Keflordin | Cefaloridine | Unidentified Pharmaceutical Company |
| Kefloridin | Cefaloridine | Unidentified Pharmaceutical Company |
| Kefolan | Cephalexin | Unidentified Pharmaceutical Company |
| Kefral | Cefaclor | Unidentified Pharmaceutical Company |